Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.
X
Announcing new Tapestri Platform updates including lowered input threshold and expanded heme-onc menu. Learn More
X
Scientific presentation

Issues faced when using targeted NGS panels in the clinic for diagnosis, prognosis, and treatment


Alexander Perl, MD
Catherine Smith, MD

Description

Large cancer centers have adopted Next Generation Sequencing (NGS) in the clinic for diagnosis, prognosis, and treatment decisions. Dr. Catherine Smith, from UCSF, discusses the issues faced with targeted panels in the clinic and the differences between amplicon and hybridization methods. While Dr. Alexander Perl, from the University of Pennsylvania, discusses the findings in their collaborative CHRYSALIS study of the FLT3 inhibitor Gilteritinib in relapsed/refractory AML where they used quantifiable single-cell DNA analysis to enable dynamic therapy selection.



VIEW


Scientific presentation
Do More Single Cell with Less – Tapestri Platform Expansion for Hematologic Malignancy Research
Koichi Takahashi, MD, PhD, MD Anderson Cancer Center & Jim Flynn, PhD, Mission Bio
(2021)
Scientific presentation
Women in Single Cell: Elucidating Clonal Evolution and Clonotype-Immunophenotype Relationships in Myeloid Malignancies with Single-Cell Analysis
Linde Miles, PhD, Memorial Sloan Kettering Cancer Center
(2021)
Scientific presentation
Meet the Authors: Single-cell Multiomics Analysis of Clonal Evolution in Myeloid Malignancies
Ross Levine, MD, Memorial Sloan Kettering Cancer Center
(2021)
Scientific presentation
Utilizing Single-Cell Multi-Omics to Uncover its Evolution and Resistance Mechanisms of AML
Cathy Smith, MD, UCSF
(2021)
REQUEST QUOTE